MediaCenter | powered by The NewsMarket
Additional broadcast-quality multimedia content is available free for registered journalists
.
Novo Nordisk Announces First Half Year 2010 Results: Operating Profit Up 19%
Phase 2 Data for Ultra-Long-Acting Insulin Degludec Show Potential to Effectively Lower Blood Sugar
The Novo Nordisk Foundation Donates €118 Million to New Research Centre in Copenhagen
LoginRegister
email address
remember me